Frank D'amelio | search
Click here to view Frank D'amelio news from 60+ newspapers.
Bookmark or Share- Deloitte’s CFO Program Names Frank D’Amelio as CFO-in-ResidenceDeloitte announced today that Frank D’Amelio, former executive vice president and chief financial officer at Pfizer Inc., has been appointed independent senior advisor, U.S. CFO Program, Deloitte LLP, serving as the CFO-in-residence.
- Frank D’Amelio, CFO-in-Residence, on Driving Strategy - WSJFrank D’Amelio, retired CFO of Pfizer Inc., is an independent senior advisor to Deloitte LLP, and as CFO-in-Residence of the CFO Program, provides guidance and counsel to staff and...
- Deloitte's CFO Program Names Frank D'Amelio as CFO-in-ResidenceD'Amelio served as executive vice president and chief financial officer of Pfizer Inc. from 2007 to 2022. During his tenure, he was responsible for finance, business...
- Pfizer CFO D'Amelio to retire after 15 years at companyNov 17 (Reuters) - Pfizer Inc (PFE.N) said on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company. The drugmaker has started an external search...
- Pfizer Announces Retirement of Chief Financial Officer Frank D’AmelioNEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that Frank D’Amelio will retire from his position as Chief Financial Officer and Executive Vice President of Global Supply at Pfizer after a nearly 15 year distinguished career with the Company.
More
